Clinical Trials
2 trialsNCT05155215 2021-12-13
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1/2 Unknown
NCT00750126 2011-01-19
RICE
University Hospital, Clermont-Ferrand
Phase 2 Unknown